share_log
Moomoo 24/7 ·  Apr 18 12:18
Aileron Therapeutics Shares Are Trading Higher After Ladenburg Thalmann Maintained a Buy Rating on the Stock and Raised Its Price Target From $9 to $19. Also, the Company Filed U.S. Patent Application Number 20240124518 Titled "Methods For Preparing Purified Polypeptide Compositions"
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment